SARS-CoV-2 microfluidic antigen point-of-care testing in Emergency Room patients during COVID-19 pandemic
Related Experiment Video
Updated: Oct 15, 2025
05:34
Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP
Published on: September 8, 2023
947
Elisa Burdino1, Francesco Cerutti1, Francesco Panero2
1Amedeo di Savoia Hospital, ASL Città di Torino, Turin, Italy.
Journal of Virological Methods
|October 23, 2021
Abstract:
In Emergency Room, Point-of-care antigen testing for SARS-CoV-2 antigen can expedite clinical strategies for patient management. We tested 1,232 consecutive patients during Italian second wave peak using the recent LumiraDx microfluidic assay. This assay showed high concordance (96.9 %), sensitivity and specificity compared to molecular testing, being highly valuable.
